Rhino-occulo-cerebral mucormycosis in patients with type 2 diabetes mellitus.
Four successive cases of rhino-occulo-cerebral mucormycosis [ROCM] in patients suffering from type 2 diabetes mellitus are described. The clinical presentation is given in details. The need for high degree of suspicion, prompt diagnosis and complete surgical evacuation of inflammatory mass; and prompt initiation of antifungal therapy is discussed. The side effects associated with amphoterecin and issue regarding its total dosage is discussed.
Talwalkar
Pradeep G
PG
S.L. Raheja Hospital, Mumbai.
D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000188:drug therapy / Q000382:microbiology*; D048909:Diabetes Complications; D003924:Diabetes Mellitus, Type 2; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009091:Mucormycosis / Q000188:drug therapy / Q000382:microbiology*; D009668:Nose Diseases / Q000188:drug therapy / Q000382:microbiology*; D010254:Paranasal Sinus Diseases / Q000188:drug therapy / Q000382:microbiology*
D000935:Antifungal Agents